BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33528758)

  • 1. Validation of prognostic significance of the proposed uniform classification framework in neuroendocrine neoplasms of the breast.
    Yang L; Roy M; Lin H; Shen Y; Albarracin C; Huo L; Chen H; Wei B; Bedrosian I; Bu H; Wu Y
    Breast Cancer Res Treat; 2021 Apr; 186(2):403-415. PubMed ID: 33528758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine neoplasms of the breast: diagnostic agreement and impact on outcome.
    Metovic J; Cascardi E; Uccella S; Maragliano R; Querzoli G; Osella-Abate S; Pittaro A; La Rosa S; Bogina G; Cassoni P; Marchiò C; Sapino A; Castellano I; Papotti M
    Virchows Arch; 2022 Dec; 481(6):839-846. PubMed ID: 36243799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
    Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
    Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome and therapeutic impact on neuroendocrine neoplasms of the breast: a national cancer database study.
    Yang L; Lin H; Shen Y; Roy M; Albarracin C; Ding Q; Huo L; Chen H; Wei B; Bu H; Bedrosian I; Wu Y
    Breast Cancer Res Treat; 2023 Nov; 202(1):23-32. PubMed ID: 37566192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of World Health Organization 2010 Classification for Gastroenteropancreatic Neuroendocrine Neoplasms with the Prognosis of Ovarian Neuroendocrine Neoplasms: Kansai Clinical Oncology Group-Protocol Review Committee/Intergroup Study.
    Kai K; Nasu K; Nishida H; Daa T; Shikama A; Shiozaki T; Kurakazu M; Yano M; Imamura Y; Tokunaga H; Tasaki K; Iida Y; Yamada Y; Morisawa H; Nakagawa S; Fujimoto E; Tsuruta T; Matsumoto H; Arakawa A; Nonaka M; Takano H; Ushiwaka T; Mori T; Ito K; Motohashi T; Teramoto N; Yamada T
    Neuroendocrinology; 2021; 111(4):320-329. PubMed ID: 32097950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. World Health Organization grading classification for pancreatic neuroendocrine neoplasms: a comprehensive analysis from a large Chinese institution.
    Yang M; Zeng L; Ke NW; Tan CL; Tian BL; Liu XB; Xiang B; Zhang Y
    BMC Cancer; 2020 Sep; 20(1):906. PubMed ID: 32962649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Non-coding RNAs in Pulmonary Neuroendocrine Neoplasms.
    Narayanan D; Mandal R; Hardin H; Chanana V; Schwalbe M; Rosenbaum J; Buehler D; Lloyd RV
    Endocr Pathol; 2020 Sep; 31(3):254-263. PubMed ID: 32388776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
    Tang LH; Basturk O; Sue JJ; Klimstra DS
    Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuroendocrine neoplasms : Two families with distinct features unified in one classification (German version)].
    Klöppel G
    Pathologe; 2019 May; 40(3):211-219. PubMed ID: 30969346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of clinicopathologic features and p53 mutation in neuroendocrine neoplasms of the breast: experience from a large academic center.
    Shafi S; Hu Y; Parwani AV; Ding Q; Li Z
    Breast Cancer Res Treat; 2022 Dec; 196(3):463-469. PubMed ID: 36260193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and genomic analyses of neuroendocrine neoplasms of the breast.
    Wei Y; Ke X; Yu J; Jing Q; Bu H; Zeng X; Wei B
    Mod Pathol; 2022 Apr; 35(4):495-505. PubMed ID: 34728787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological features and outcome for neuroendocrine neoplasms of gastroesophageal junction: A population-based study.
    Zhang P; Wang W; Lu M; Zeng C; Chen J; Li E; Tan H; Wang W; Yu X; Tang Q; Zhao J; Shen L; Li J
    Cancer Med; 2018 Sep; 7(9):4361-4370. PubMed ID: 30062861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database.
    Cao LL; Lu J; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Chen QY; Lin M; Tu RH; Huang CM
    Eur J Surg Oncol; 2018 Oct; 44(10):1628-1633. PubMed ID: 29983275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Metastatic Patterns Among Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Nonneuroendocrine Carcinomas of Various Primary Organs.
    Park HK; Kwon GY
    J Korean Med Sci; 2023 Mar; 38(11):e85. PubMed ID: 36942393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and immunohistochemical profiling of small cell and large cell neuroendocrine carcinomas of the breast.
    Bean GR; Najjar S; Shin SJ; Hosfield EM; Caswell-Jin JL; Urisman A; Jones KD; Chen YY; Krings G
    Mod Pathol; 2022 Oct; 35(10):1349-1361. PubMed ID: 35590107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Therapeutic Concepts and Latest Diagnostic Advancements Regarding Neuroendocrine Tumors of the Gynecologic Tract.
    Georgescu TA; Bohiltea RE; Munteanu O; Furtunescu F; Lisievici AC; Grigoriu C; Gherghiceanu F; Vlădăreanu EM; Berceanu C; Ducu I; Iordache AM
    Medicina (Kaunas); 2021 Dec; 57(12):. PubMed ID: 34946283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal.
    Rindi G; Klimstra DS; Abedi-Ardekani B; Asa SL; Bosman FT; Brambilla E; Busam KJ; de Krijger RR; Dietel M; El-Naggar AK; Fernandez-Cuesta L; Klöppel G; McCluggage WG; Moch H; Ohgaki H; Rakha EA; Reed NS; Rous BA; Sasano H; Scarpa A; Scoazec JY; Travis WD; Tallini G; Trouillas J; van Krieken JH; Cree IA
    Mod Pathol; 2018 Dec; 31(12):1770-1786. PubMed ID: 30140036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Clinical Significance of Neuroendocrine Features in Invasive Breast Carcinomas.
    Lai BS; Tsang JY; Poon IK; Shao Y; Chan SK; Tam FK; Cheung SY; Shea KH; Tse GM
    Oncologist; 2020 Sep; 25(9):e1318-e1329. PubMed ID: 32472950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification and Prognostic Stratification of Bronchopulmonary Neuroendocrine Neoplasms.
    Oka N; Kasajima A; Konukiewitz B; Sakurada A; Okada Y; Kameya T; Weichert W; Ishikawa Y; Suzuki H; Sasano H; Klöppel G
    Neuroendocrinology; 2020; 110(5):393-403. PubMed ID: 31422400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The classification of neuroendocrine neoplasms of the breast and its clinical relevance.
    Uccella S
    Virchows Arch; 2022 Jul; 481(1):3-12. PubMed ID: 34698887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.